Cargando…
AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis
Recent development of the chemical inhibitors specific to oncogenic KRAS (Kirsten Rat Sarcoma 2 Viral Oncogene Homolog) mutants revives much interest to control KRAS-driven cancers. Here, we report that AIMP2-DX2, a variant of the tumor suppressor AIMP2 (aminoacyl-tRNA synthetase-interacting multi-f...
Autores principales: | Kim, Dae Gyu, Choi, Yongseok, Lee, Yuno, Lim, Semi, Kong, Jiwon, Song, JaeHa, Roh, Younah, Harmalkar, Dipesh S., Lee, Kwanshik, Goo, Ja-il, Cho, Hye Young, Mushtaq, Ameeq Ul, Lee, Jihye, Park, Song Hwa, Kim, Doyeun, Min, Byung Soh, Lee, Kang Young, Jeon, Young Ho, Lee, Sunkyung, Lee, Kyeong, Kim, Sunghoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095880/ https://www.ncbi.nlm.nih.gov/pubmed/35546148 http://dx.doi.org/10.1038/s41467-022-30149-2 |
Ejemplares similares
-
Data on optimization of expression and purification of AIMP2-DX2 protein in Escherichia coli
por: Jha, Roshan, et al.
Publicado: (2017) -
Anticancer Activity of Pyrimethamine via Ubiquitin Mediated Degradation of AIMP2-DX2
por: Kim, Dae Gyu, et al.
Publicado: (2020) -
An Isoform of the Oncogenic Splice Variant AIMP2-DX2 Detected by a Novel Monoclonal Antibody
por: Kim, Dae Gyu, et al.
Publicado: (2020) -
Synthesis and discovery of the first potent proteolysis targeting chimaera (PROTAC) degrader of AIMP2-DX2 as a lung cancer drug
por: Lee, BoRa, et al.
Publicado: (2022) -
AIMP3 Deletion Induces Acute Radiation Syndrome-like Phenotype in Mice
por: Kim, Doyeun, et al.
Publicado: (2018)